small molecule

TOPICORT LP

DESOXIMETASONE

Loss of exclusivity—loss of exclusivity

CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand name	TOPICORT LP
Active ingredient	DESOXIMETASONE
Strength	0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	CREAM
Route	TOPICAL
Modality	Small molecule
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.